0
0
0
s2sdefault

A plant-based medication may be the solution to nicotine and cigarette addiction, and an ASU professor is helping lead the study.

Scott Leischow, director and professor at the College of Health Solutions, is heading the Arizona site for a clinical trial on the naturally occurring smoking cessation drug cytisinicline. According to Achieve Life Sciences CEO John Bencich, the Phase 3 ORCA-2 clinical trial is being run across 15 centers around the U.S. and the company hopes to enroll 750 participants in the 12-week trial. Leischow said people are paid up to $1,950 as compensation for participating in the study [...]